Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020

$3,495.00

The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

Publication date
October 2020
Number of pages
2,400+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP2063

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.

 

This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of licensing agreements from 2014 to 2020.

 

There has been a long standing willingness for parties to enter licensing deals. Such deals enable both parties to benefit from the upside of a big R&D win, whilst mitigating the risks of going it alone in the risky preclinical and clinical development stages.

 

Licensing is a specific type of partnering deal whereby the parties to the deal agree to commercialize a compound, product or technology.

 

Specifically, licensing is the granting of permission to use intellectual property rights, such as trademarks, patents, or technology, under defined conditions

 

There are several forms of licensing deal. Traditional licensing arrangement whereby an owner of intellectual property (the licensor) provides access to its technology to another company (the licensee) in return for agreed payments and royalties on subsequent sales of product(s) derived from the intellectual property.

 

In more recent times, licensing is often the outcome of a successful period of collaboration on the research and development of a technology or compound, resulting in a product which can be commercialized. In this situation, the licensing agreement governs who has permission to commercialize and what payments are due should commercialization proceed.

 

Other forms of licensing such as sub-licensing and cross-licensing are also explored, with examples provided together with listing of recent deals in pharma, biotech and diagnostics.

 

The report provides a detailed understand and analysis of how and why companies enter licensing deals. The majority of deals are multicomponent whereby the licensee retains either a right or option to license to commercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.

 

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

 

This report contains a comprehensive listing of all licensing deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

 

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

 

The initial chapters of this report provide an orientation of licensing deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in licensing as well as a discussion on the merits of the type of deal.

 

Chapter 3 provides an overview of the structure of licensing deals. The chapter includes numerous case studies to enable understanding of both pure licensing deals and multicomponent deals where collaborative R&D forms a part.

 

Chapter 4 provides a review of the leading licensing deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

 

Chapter 5 provides a review of the top 25 most active biopharma companies in licensing. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

 

Chapter 6 provides a comprehensive review of licensing financials for deals announced since 2014, including headline value, upfront, milestone payments and royalty rates, providing both benchmark data and access to individual deal financials.

 

Chapter 7 provides a comprehensive and detailed review of licensing deals signed and announced since 2014 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

 

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

 

The report also includes numerous table and figures that illustrate the trends and activities in licensing deal making since 2014.

 

In addition, a comprehensive appendix is provided organized by licensing company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

In conclusion, this report provides everything a prospective dealmaker needs to know about licensing partnering in the research, development and commercialization of technologies and products.

 

Key benefits

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 provides the reader with the following key benefits:

 

  • In-depth understanding of licensing partnering deal trends since 2014
  • Analysis of the structure of licensing agreements with numerous real life case studies
  • Comprehensive listing of licensing deals since 2014, together with deal terms, value and press release
  • Comprehensive access to actual licensing contracts entered into by the world’s life science companies
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

 

Report scope

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading life science companies worldwide.        

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 includes:

 

  • Trends in licensing dealmaking in the biopharma industry since 2014
  • Analysis of licensing deal structure
  • Case studies of real-life licensing deals
  • Comprehensive listing of licensing deals since 2014
  • Access to licensing contract documents
  • Key financial bnchmarks for headline, upfront, milestone and royalty rates
  • The leading licensing deals by value since 2014
  • Most active licensing dealmakers since 2014
  • The leading licensing partnering resources

 

In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 available deals and contracts are listed by:

 

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

 

Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.

 

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 - 2020 report provides comprehensive access to available contract documents for licensing deals. Analyzing actual contract agreements allows assessment of the following:

 

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How do milestone align with clinical stage development phases?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2014-2020 provides the reader with the following key benefits:

 

  • In-depth understanding of licensing partnering deal trends since 2014
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  •  Identify leading licensing deals by value since 2014
  • Identify the most active licensing dealmakers since 2014
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Full listing of  licensing deals by company A-Z, deal value, phase of development, deal type, therapy and technology focus
  • Comprehensive access to licensing deals entered into by the world’s biopharma companies, together with contract documents if available
  • Detailed access to actual licensing contracts entered into by the leading fifty big pharma and big biotech companies
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in licensing deal making

 

2.1. Introduction

2.2. Definition of licensing deals

2.3. Success factors for licensing deals

2.4. When licensing can be useful

2.5. Attributes of licensing deals

2.6. Trends in licensing deals since 2014

2.6.1. Licensing deal making by year since 2014

2.6.2. Licensing deal making by phase of development since 2014

2.6.3. Licensing deal making by industry sector since 2014

2.6.4. Licensing deal making by therapy area since 2014

2.6.5. Licensing deal making by technology type since 2014

2.6.6. Licensing deal making by most active company since 2014

2.7. Option to license

2.8. Adding co-promotion to the mix

2.9. The future of licensing deals

 

Chapter 3 – Overview of licensing deal structure

 

3.1. Introduction

3.2. Pure versus multi-component licensing deals

3.3. Pure licensing agreement structure

3.3.1. Example licensing agreements

3.3.1.a. Case study 1: Ignyta – Nerviano Medical Sciences

3.3.1.b. Case study 2: Sanofi - Pozen

3.4. Licensing rights as part of a wider alliance agreement

3.4.1. Example licensing clauses

3.4.1.a. Case study 3: 4D Molecular Therapeutics – UniQure

3.4.1.b. Case study 4: Kyowa Hakko Kirin – Ultragenyx Pharmaceuticals

3.4.2. Example licensing option right clauses

3.4.2.a. Case study 5: Forest Laboratories - Trevena

3.4.2.b. Case study 6: Abbvie – Receptos

 

Chapter 4 – Leading licensing deals

 

4.1. Introduction

4.2. Top licensing deals by value

 

Chapter 5 – Top 25 most active licensing dealmakers

 

5.1. Introduction

5.2. Top 25 most active licensing dealmakers

 

Chapter 6 – Licensing deal term financials

 

6.1. Introduction

6.2. Licensing partnering headline values

6.3. Licensing deal upfront payments

6.4. Licensing deal milestone payments

6.5. Licensing royalty rates

 

Chapter 7 – Licensing contract directory since 2014

 

7.1. Introduction

7.2. Licensing deals with contracts since 2014

 

Appendices

 

Appendix 1 – Licensing dealmaking by companies A-Z

Appendix 2 – Licensing dealmaking by industry sector

Appendix 3 – Licensing dealmaking by stage of development

Appendix 4 – Licensing dealmaking by therapy area

Appendix 5 – Licensing dealmaking by technology type

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

 

Figure 1: Definition of licensing

Figure 2: Situations where licensing can prove useful

Figure 3: Key attributes of a licensing deal

Figure 4: Trends in licensing deal announcements since 2014

Figure 5: Licensing deals signed at each phase of development since 2014

Figure 6: Licensing deals by industry sector since 2014

Figure 7: Licensing deals by therapy area since 2014

Figure 8: Licensing deals by technology type since 2014

Figure 9: Top 25 most active licensing dealmakers sinnce 2014

Figure 10: Licensing agreements – what should a contract include?

Figure 11: Components of the licensing deal structure

Figure 12: Top licensing deals by value since 2014

Figure 13: Most active licensing dealmakers since 2014

Figure 14: Licensing deals with a headline value

Figure 15: Licensing deals with an upfront value

Figure 16: Licensing deals with a milestone value

Figure 17: Licensing deals with a royalty rate value

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2A, 2bPrecise, 2M, 2X Oncology, 3B Pharmaceuticals, 3D Medicines, 3M, 3M Drug Delivery Systems, 3P Biopharmaceuticals, 3rd People’s Hospital of Shenzhen, 3SBio, 4D Molecular Therapeutics, 4D Pharma, 4SC, 5LINX, 8E6Tong, 23andMe, 48Hour Discovery, A&B Company, A*STAR Agency for Science, Technology and Research, A1 Group, AADi, AAVLife, Abba Import Export, AB Biosciences, Abbisko Therapeutics, Abbott Laboratories, Abbott Vascular Devices, Abbvie, Abcam, AbCellera, AbCheck, AbClon, Abcuro, Ab E Discovery, Abeona Therapeutics, Abic Marketing, Abide Therapeutics, Ability Pharmaceuticals, Ab Initio, Abiogen Pharma, Abiomed, ABL Bio, Ablexis, Ablynx, AbMed, Aboundbio, Abpro, AbSci, Absorption Systems, Abveris, ABX, Abyrx, Abzena, Acacia Pharma, Acacia Research, ACADIA Pharmaceuticals, Acasti Pharma, Accellta, Accent Therapeutics, Accera Pharmaceuticals, Access Pharmaceuticals, Accord Healthcare, Acelity, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acepodia, Acer Therapeutics, Acerus, ACE Solutech, Acetylon Pharmaceuticals, Achieve Life Science, Achillion Pharmaceuticals, AC Immune, Aclaris Therapeutics, Acorda Therapeutics, Acoustic MedSystems, Acrotech Biopharma, Actavis (acquired by Watson), ACT Biotech, Actelion, Acticor Biotech, Actinobac Biomed, Active Biotech, Active Motif, ActiveSite, ActLight, Actuated Cardio Engineering, Actuated Medical, Acturum Life, Acucela, Acumen Pharmaceuticals, Acura Pharmaceuticals, Acutus Medical, Adagene, AdAlta, Adama, Adamis Pharmaceuticals, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, Adapt Pharma, AdaptVac, Adare Pharmaceuticals, Adarza BioSystems, ADC Therapeutics, Addex Therapeutics, Adept Neuro, Adhesys Medical, Adial Pharmaceuticals, Adicet Bio, Adimab, Aditx Therapeutics, Adlai Nortye, Admedus, Adocia, ADT Pharmaceuticals, Aduro BioTech, Advaite, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced BioInformatics, Advanced Biological Laboratories, Advanced BioMatrix, Advanced Catheter Therapies, Advanced Dosage Forms, Advanced Medical Solutions, Advanced Nuclear Medicine Ingredients, Advanced Proteome Therapeutics, Advance Pharmaceutical, Advanz Pharma, Advaxis, Adverum Biotechnologies, Aegerion Pharmaceutical, Aegis Therapeutics, Aelan Cell Technologies, Aelian Biotechnology, Aerami Therapeutics, Aeras, Aerial BioPharma, Aerie Pharmaceuticals, Aerogen, Aeromics, Aerpio Pharmaceuticals, AEterna Zentaris, Aethlon Medical, Aevi Genomic Medicine, Aevitas Therapeutics, AffaMed Therapeutics, Affibody, Affilogic, Affimed Therapeutics, Affinia Therapeutics, Affinivax, Affymetrix, AffyXell Therapeutics, AFT Pharmaceuticals, Agalimmune, AGC Asahi Glass, Agensys, Agenus Bio, AgeX Therapeutics, Agilis Biotherapeutics, Agios Pharmaceuticals, AgMedica Bioscience, AgomAb Therapeutics, AgonOx, AgPlenus, AgriCann Solutions, Agricultural Research Service, AGTC, AiCuris, AIkido Pharma, AIMM Therapeutics, Aimmune Therapeutics, AirWare Labs, AIT Therapeutics, AiVita Biomedical, AJU Pharma, Akaal Pharma, Akari Therapeutics, AkaRx, Akcea Therapeutics, Akebia Therapeutics, Akero Therapeutics, Akers Biosciences, Akeso Biopharma, Akili Interactive Labs, Akonni Biosystems, Akorn, Akouos, Akrevia Therapeutics, Akriveia Therapeutics, Albany Molecular Research, Alba Therapeutics, Albert Einstein College of Medicine, Albion, Alcon Laboratories, Alcyone Lifesciences, Alder Biopharmaceuticals, Aldevron, Aldeyra Therapeutics, Alector, Aleva Neurotherapeutics, Alexion Pharmaceuticals, Alexza Pharmaceuticals, Alfasigma, Algenex, Aligo, Aligos Therapeutics, Alimentary Health, Alimera Sciences, AliveCor, Alive Sciences, Alivio Therapeutics, Alize Pharma, ALK-Abello, Alkahest, Alkem Laboratories, Alkermes, Allakos, AllCells, Allegro Ophthalmics, Allele Biotechnology and Pharmaceuticals, Allergan, Allergan (name changed from Actavis), AllerGenis, Allergopharma, Alliance BioEnergy Plus, Alliance Pharma, Allied-Bristol Life Sciences, Allied Corp, Allied Minds, Alligator Bioscience, Allogene Therapeutics, Alloksys Life Sciences, AlloVir, AllyAlign Health, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Cancer Technologies, Alphaeon, Alphamab Biopharmaceuticals, Alpine Immune Sciences, ALS Biopharma, Altamira Bio, Altamira Pharma, Altan Pharma, Alteogen, Alternavida, Altor BioScience, Altum Pharmaceuticals, Altus Formulation, Alvit LCS Pharma, Alvogen, Alvotech, Alytas Therapeutics, Alzamend Neuro, AlzeCure Pharma, Alzyn, Amag Pharmaceuticals, Amarantus BioSciences, Amarillo Biosciences, Amarin, Ambrx, Ambys Medicines, AM Chemicals, AMD Insight, Amegabiotech, A Menarini Diagnostics, Amendia, Amend Surgical, American BriVision, American Cancer Society, American CryoStem, American Speech-Language-Hearing Association, Amerigen Pharmaceuticals, Amfora, Amgen, Amherst Pharmaceuticals, Amneal Pharmaceuticals, AMO Pharma, AmorChem, Amorsa Therapeutics, AmplyCell, Amplyx Pharmaceuticals, AMR, Amsel Medical, Amunix, Amyris, AN2 Therapeutics, AnaBios, Anacor Pharmaceuticals, Anagenesis Biotechnologies, Anahit, Analytical Testing Laboratory, ANANDA Scientific, AnaptysBio, Anatara Lifesciences, Anavex Life Sciences, Anchiano Therapeutics, Andor Pharmaceuticals, Angelini Pharma, AnGes MG, Angiochem, Angiocrine Bioscience, Angiodynamics, Angion Biomedica, Angionetics, AngioSoma, Angiostem, AnHeart Therapeutics, Anika Therapeutics, Anima Biotech, Animal Life Sciences, ANI Pharmaceuticals, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, Annias Immunotherapeutics, ANP Technologies, Ansell, Antares Pharma, Antengene, Anthera Pharmaceuticals, Anthos Therapeutics, Antibe Therapeutics, Antibody Solutions, Antigen Express, Antisense Therapeutics, Antitope, AntriaBio, Apceth, APC Therapeutics, Apeiron Biologics, Aperion Biologics, Apex Global Brands, Apexian Pharmaceuticals, Apexigen, Aphria, Aplagon, Apogenix, ApolloBio, Apollomics, Apollo Therapeutics, Apotex, Appello Pharmaceuticals, Appili Therapeutics, Applied BioCode, Applied Biology, Applied BioSciences, Applied Botanics, Applied DNA Sciences, Applied Molecular Transport, Applied StemCell, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricity Health, Apricus Biosciences, APRINOIA Therapeutics, Apsen Farmacutica, AptaBio Therapeutics, Aptarion biotech, Aptar Pharma, Aptinyx, Aptose Biosciences, Aquinox Pharmaceuticals, Aragen Bioscience, Aralez Pharmaceuticals, Aratana Therapeutics, Arbele, Arbor Biotechnologies, ArborGen, Arbutus, Arcadia Biosciences, Arcadia Consumer Healthcare, ArcDia, Arcellx, Arch Biopartners, ArcherDX, Arcis Biotechnology, Arcoral Pharma, ARC Therapeutics, ArcticDx, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardelyx, Arecor, Arena Pharmaceuticals, Ares Genetics, arGEN-X, Argentum Pharmaceuticals, argenx, Argon Medical Devices, Argos Therapeutics, Ariad Pharmaceuticals, Aridis Pharmaceuticals, Ariosa Diagnostics, Arista Cereal Technologies, Aristea Therapeutics, Arizona State University, Arjuna Naturals, Ark Biosciences, ArmaGen, Armetheon, ARMO Biosciences, Arno Therapeutics (inactive since 2017), Aro Biotherapeutics, ArQule, Arradiance, Arrakis Therapeutics, Array Biopharma, Arrien Pharmaceuticals, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, Arrys Therapeutics, Arsanis Biosciences, Artelo Biosciences, Arthrex, Artios Pharma, Artizan Biosciences, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Asana Biosciences, Asana Medical, Ascendance Biotechnology, Ascenion, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, ASC Therapeutics, Aseptix, Asieris MediTech, ASKA Pharmaceuticals, AskAt, AS Kevelt, Asklepios Biopharmaceutical, Aslan Pharma, Aspen Holding, Aspen Park Pharmaceuticals, Aspen Pharmacare Canada, Aspire Health Science, Aspyrian Therapeutics, Assembly Biosciences, Astellas Pharma, Astellas Pharma Europe, Asterias Biotherapeutics, Astex Pharmaceuticals, AstraZeneca, Astute Medical, Asuragen, Asylia Therapeutics, Asymptote, Atara Biotherapeutics, Athenex, Athersys, Atlante Biotech, Atlantic Healthcare, Atomwise, Atopix, Atossa Genetics, Atreca, Attune Medical, ATUM, Atvio Biotech, aTyr Pharma, Aucta Pharmaceuticals, Audax Medical, Audentes Therapeutics, Audion Therapeutics, Auditus, AUM Biotech, Aura Biosciences, Auransa, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Aurobindo Pharma, Aurora Cannabis, AusHealth, Australian Research Council, Austrianova Singapore, Autifony Therapeutics, Autolus, Automation Anywhere, Autotelic, Autotelic BIO, Auven Therapeutics, Auxly Cannabis Group, Auxogyn, Avacta, Avactis Biosciences, Avadel Pharmaceuticals, Avalanche Biotechnologies, Avalon GloboCare, AvantGen, Avaria Health & Beauty, Avectas, Avenue Therapeutics, AVEO Oncology, AveXis, Avicanna, Avidity Biosciences, Avillion, Avion Pharmaceuticals, Avior Bio, Aviragen Therapeutics, Avita Medical, Avitide, Avrobio, Axcelead Drug Discovery Partners, AXIM Biotechnologies, Axiogenesis, Axiom Worldwide, Axis Therapeutics, AxoSim, Axovant Gene Therapies, Axsome Therapeutics, Axxam, Axxess Pharma, Ayala Pharmaceuticals, Aytu BioScience, Azaya Therapeutics, Aziyo Biologics, AzurRx BioPharma, Back-A-Line, Back Bay Scientific, Bactevo, Baergic Bio, Baker IDI Heart and Diabetes Institute, Banyan Biomarkers, Basilea Pharmaceutica, BAS Research, Batavia Biosciences, BATM, Battelle, Batu Biologics, Baudry Laboratory, Bausch & Lomb, Bausch Health Companies, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Animal Health, Bayer CropScience, Bayer Healthcare, Bayer Schering Pharma, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Miraca Genetics Laboratories, BayPAT, Bay State Milling Company, Bazelet, BB100, BDD Pharma, Beacon Discovery, Beactica, Beam Therapeutics, Beckman Research Institute of City of Hope, Becton Dickinson, BeiGene, Beijing SL Pharma, Beijing Strong Biotechnologies, Beike Biotech, Belfor, Bellerophon Therapeutics, Bellicum Pharmaceuticals, Bellus Health, Ben-Gurion University, Benaroya Research Institute, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benson Hill Biosystems, Berkeley Lights, Berlin Chemie, Beroni Group, Bertech Diagnostics, Besins Healthcare, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, BetterLife Pharma, BevCanna, BexPharm, BGN Technologies, Bhang, BHV Pharmaceuticals, Bial, BIA Separations, Bicycle Therapeutics, Biedermann Motech, Bill and Melinda Gates Foundation, Bintai Kinden, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, bioAffinity Technologies, BioAge Labs, BioAlliance Pharma, BioArctic Neuroscience, BioArdis, biOasis Technologies, BioAtla, BioBlast Pharma, BioCardia, Biocare Medical, Biocept, Bioceros, BiocerOX Products, Biocodex, Biocon, BioCorRx, BioCryst Pharmaceuticals, Biodel, BioDelivery Sciences, Bio DG, Biodirection, BioDlogics, BioDuro, Bioeq IP, Bio Farma, BioGaia, Biogen, BioGenetics, BioGen Medical, Bioharmony Therapeutics, Biohaven Pharmaceutical Holding, BioHeart, BioHEP Technologies, BioInvent, Bioject Medical Technologies, Biokit, BioLamina, BioLegend, BiolineRX, Biolin Scientific, BioLite Japan, Biologix FZCo, BioMarin Pharmaceutical, Biomatrica, Biomed, Biomedical Advanced Research and Development Authority, Biomerica, Biomerics, bioMerieux, Biomunex Pharmaceuticals, BiomX, Bioneer, Bionomics, BioNovion, Bionovus Life Sciences, BioNTech, Bionure, BionX Medical Technologies, Bioo Scientific, Bio Palette, BioPharma Forest, BioPhausia, BioPorto, Bioprojet, Bioptic, BioQ Pharma, BioRap Technologies, BioReliance, Biosearch Technologies, BioSense Global, BioSilta, BioSkryb, Biosolution, BioSyent Pharma, Biosynth, Biotectix, Biotest, BioTheryX, Biotheus, Biotoscana Farma, Biotricity, BioVaxys, Bioventus, Bioverativ, BioWa, BioXcel, BirchBioMed, Bird Foundation, Birdie Biopharmaceuticals, Biscayne Neurotherapeutics, Bixink Therapeutics, BL&H, Blackford, Blackrock Microsystems, BlackThorn Therapeutics, Blacktrace Holdings, Blanver, BlinkBio, BliNK Biomedical, Bliss Biopharmaceutical, Bloom Science, Bluebird Bio, Bluechiip, BlueOcean Nutrascience, Blueprint Medicines, BlueRock Therapeutics, Blue Sky Biotech, Bluestar Alliance, Blue Water Vaccines, BMV Medica, BODIMETRICS, Body Labs, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bone Biologics, Bone Solutions, Bone Therapeutics, Bonutti Skeletal Innovations, Bophelo Bioscience & Wellness, Boragen, Bora Pharmaceuticals, Boryung Pharmaceutical, Bosch, Boston Pharmaceuticals, Boston Scientific, Boston Strategics, Boston Therapeutics, Boston University, Botanisol, BoyaLife, Braeburn Pharmaceuticals, BrainLAB, BrainStorm Cell Therapeutics, Branhaven, BravoVax, Breathe Active, Breathe ECig, Breathtec BioMedical, Breath Therapeutics, Breckenridge Pharmaceuticals, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, Brigham and Women's Hospital, Bright Future Pharmaceutical Lab, Brighton Biotech, Brii Biosciences, Brill Pharma, BRIM Biotechnology, Brink Biologics, Bristol-Myers Squibb, Broad Institute, BroadMed, Broda Technologies, Brown University, Bruker, Bryn Pharma, BryoLogyx, BTG, BTS Research (BTS), Buck Institute for Age Research, Bugworks, Butantan Institute, Byrne Medical, C-Bridge Capital, C2N Diagnostics, C3i, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Cadence Pharmaceuticals, Cadent, Cadila Pharmaceuticals, Caelum Biosciences, Caffeluxe, Caladrius Biosciences, Caliber Biotherapeutics, Calico, California Institute for Biomedical Research, California Institute for Quantitative Biosciences (QB3), California Institute of Technology, Calimmune, Calithera Biosciences, Calixar, Calliditas Therapeutics, Calox de Costa Rica, Calypso Biotech, Calyxt, Camarus, Cambridge Cognition, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Research Biochemicals, CamelBak, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, Canada House Wellness Group, CanBas, CANbridge Life Sciences, CancerLinQ, Cancer Prevention Pharmaceuticals, Cancer Research Technology, Cancer Research UK, Cancer Targeted Technology, CanCure, Candela, Cannabis OneFive, CannaHoldCo, CannaRoyalty, CannaSkin, Cannassure Therapeutics, CanniMed Therapeutics, CannPal Animal Therapeutics, CannScience Innovations, Canntab Therapeutics, Canopy Biosciences, Canopy Growth, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, CAO Pharmaceuticals, Capricor Therapeutics, Caprion Proteomics, Cara Therapeutics, Carbonics, Cardiff University, Cardinal Health, Cardinal Partners, Cardiogen Sciences, Cardiome Pharma, CardioSert, Cardiovascular Solutions of Central Mississippi, Cardiowise, Cardurion Pharmaceuticals, CareDx, Cargill, Caribou Biosciences, Carisma Therapeutics, Carlos Slim Health Institute, Carmel Pharma, Carmine Therapeutics, Carmot Therapeutics, Carna BioSciences, Carpegen, Carrick Therapeutics, Cascade Pure, Cascadian Therapeutics, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Casma Therapeutics, Castle Creek Pharmaceuticals, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catalyst Pharmaceutical Partners, Catalyst Pharmaceuticals, Catapult Therapy TCR, Catholic University Leuven, CavoGene LifeSciences, CB2 Therapeutics, CBD Solutions, CBT Pharmaceuticals, Ceapro, Cedars-Sinai Medical Center, Celdara Medical, Celgene, Celimmune, Celladon, Cell Care Therapeutics, Cell Design Labs, Celldex Therapeutics, Cellecta, Cellectar Biosciences, Cellectis, Cellectricon, Cellerant Therapeutics, Cellesce, CellGenix, Cell Guidance Systems, Celling Biosciences, Cellix Bio, Cell Medica, Cellmid, Cell Mogrify, CellProThera, CellSight Technologies, Cell Source, Celltech, Cell Therapy, Cell Therapy Catapult, Cellth Systems, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Cellvation, Celonic, Celsee, Celsion, Celtic Biotech, Celtis Pharm, Celularity, Celyad, Center for Cancer Research, Central Institute for Experimental Animals, Centre for Drug Design and Discovery, Centre for Drug Research and Development (CDRD), Centre For The Commercialization Of Antibodies And Biologics, Centrexion, Centro de Investigación Biomédica en Red de Salud Mental, Centurion, Cequr, Cereal Ingredients, Cerecor, Ceres, Cerevance, Certara, Certis, Cerveau Technologies, CEVA, Ceva Sante Animale, Cevec Pharmaceuticals, CG Oncology, cGreen, Chameleon BioSurfaces, Changchun BCHT Biotechnology, Changshan Pharm, Chaperone Technologies, Charles River Laboratories, Charleston Laboratories, Chart Industries, CheckedUp, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Chelexa Biosciences, Chembio Diagnostics, Chemesis, Chemi Pharmaceutical, ChemoCentryx, Chemstar, Chengdu Gaotong Isotope, Cheplapharm Arzneimittel, Chi-Med, Chiesi Farmaceutici, Children's Cancer Institute Australia for Medical Research, Children's Hospital Boston, Children's Hospital of Philadelphia, Childrens Medical Center, Chimerix, China Medical System, China National Biotech Group (CNBG), China Oncology Focus, China State Institute of Pharmaceutical Industry (CIPI), Chinook Therapeutics, Chiome Bioscience, Chiromics, Chondrial Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, Chongqing Lummy Pharma, ChromaDex, Chroma Therapeutics, Chromocell, Chugai Pharmaceutical, Chugai Pharma Marketing, Cibus Global, Cidara Therapeutics, Cilag AG, CimCure, Cimtech, Cincinnati Children’s Hospital Medical Center, CinCor Pharma, Cinda Bio-Pharmaceutical, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circassia, Circulogene, Cirle, Cisen Pharma, Citius Pharmaceuticals, Citron Pharma, City of Hope, Civetta Therapeutics, CiVi Biopharma, CJ Corp, CJPS Healthcare Supplies & Equipment, Clal Biotech, Claremont BioSolutions, Clarity Pharmaceuticals, ClearLight Biotechnologies, ClearLight Diagnostics, Clearside Biomedical, Clementia Pharmaceuticals, Cleveland Clinic, Cleveland Diabetes Care, Cleveland Diagnostics, Clevexel Pharma, Click Therapeutics, Clinical Genomics, Clinical Laserthermia Systems (CLS), Clinica Ruiz, Clinigen, Clontech Laboratories, Clover Therapeutics, Clovis Oncology, CMC Biologics, CMS Medical, CNA Development, CNS Pharmaceuticals, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Coapt, CoapTech, Cochlear, Cocoon Biotech, Cocrystal Pharma, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogentix Medical, Cognoa, Coherus Biosciences, Cold Spring Harbor, Collegium Pharmaceuticals, Collplant, Colorcon, Columbia Care, Columbia Laboratories, Columbia Technology Ventures, Columbia University, CombiGene, Comercializadora BioRenal, Commense, Common Sense, Compassionate Care Center of New York, Complix, Compugen, Conatus Pharmaceuticals, Concerto HealthAI, Concordia Healthcare, Concortis Biosystems, ConforMIS, Confo Therapeutics, Conmed, Consilient Health, ConsortiaTX, Contamac, Context Therapeutics, Contextual Genomics, ContraFect, ContraVir Pharmaceuticals, Convelo Therapeutics, Convergence Pharmaceuticals, ConverGene, Cook Biotech, Copernicus Therapeutics, Corbin Therapeutics, Corbus Pharmaceuticals, Cordis, Corestem, Corgenix Medical, Corino Therapeutics, CorMedix, Cornell University, Coronado Biosciences, Correvio Pharma, Corsair Pharma, CorTechs Labs, Cortendo, Corteva Agriscience, Cortex Pharmaceuticals, Cortexyme, Cortice Biosciences, Corvidia Therapeutics, Corvium, Corvus Pharmaceuticals, Cosmo Pharmaceuticals, COUR Pharmaceutical, Covalon Technologies, Covance, Covidien, Create Vaccine Company, Creative Medical Technologies, Crescendo Biologics, Crescita Therapeutics, Cresset, CRISPR Therapeutics, Critical Diagnostics, Critical Path Services, Crossbeta Biosciences, Crosscare, Crown Bioscience, Crown Laboratories, CR Pharma, CRT Pioneer Fund, Cryolife, Crystal Bioscience, CrystalGenomics, CSC Pharmaceuticals, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTC Bio, CTI BioPharma, CTT Pharmaceutical, CTX Technology, Cue Biopharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cumulus Oncology, Curadev Pharma, CureMetrix, CURE Pharmaceutical, Cures Within Reach, CureTech, Curetis, CureVac, Curis, Curium, Currax Pharmaceuticals, CURx Pharmaceuticals, Cutanea Life Sciences, Cutia Therapeutics, Cutting Edge Healthcare, CvergenX, Cyclacel Pharmaceuticals, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclica, Cyclopharm, Cygnus, CymaBay Therapeutics, Cynata Therapeutics, Cyndea Pharma, Cyntec, Cyon Therapeutics, Cypralis, Cypress Pharmaceutical, Cyprium Therapeutics, Cyrenaic Pharmaceuticals, Cystic Fibrosis Foundation, Cystron Biotech, Cytocom, Cytodyn, CytoImmune Therapeutics, Cytokinetics, CytoLumina Technologies, CytomX Therapeutics, Cytori Therapeutics, Cytos Biotechnology, CytoSen Therapeutics, Cytovant Sciences, CYTOVIA Therapeutics, CytRx, Cyxone, D&A Pharma, D. Western Therapeutics Institute, D2M, Daewoong Pharmaceutical, Daiichi Sankyo, Dainippon Sumitomo Pharma, Daktari Diagnostics, Dalhousie University, Dana-Farber Cancer Institute, DARA BioSciences, Dare Bioscience, Dartmouth College, DarwinHealth, DAS Therapeutics, DATANet Software Development, Dauntless Pharmaceuticals, Debiopharm, Dechra Pharmaceuticals, Decibel Therapeutics, Deciphera Pharmaceuticals, de Duve Institute, Deerfield Management, Defense Advanced Research Projects Agency, DefiniGEN, Defyrus, DEG Productions, Deinove, Dekel Pharmaceuticals, Delcath Systems, Delivra, DelMar Pharmaceuticals, Delphi Genetics, DelSiTech, Delta 9 Cannabis, DeMelle OncoPharma, Demetrix, Denali Therapeutics, DendroCyte, Denka, Denka-KEW Genomics, Denovo Biopharma, Densitas, Densmore Pharmaceutical, Department of Veterans Affairs, DepoMed, DePuy, Derma Sciences, Dermata Therapeutics, Dermavant Sciences, Dermelix Biotherapeutics, Dermira, Desktop Genetics, Destiny Pharma, DeuteRx, Devonian Health Group, Dewpoint Therapeutics, Dexcel Pharma, DexCom, diaDexus, DiagnoCure, Diagnovus, DiA Imaging Analysis, DiaMedica, DIAN Diagnostics, Dianomi Therapeutics, Diaprost, Diatheva, DiCE Molecules, Dicerna Pharmaceuticals, Diego Pellicer, Dignity Health, Dilafor, Dimension Therapeutics, DiNAQOR, DiNonA, Disc Medicine, Discuva, Distributed Bio, Diurnal, Dixi, DKSH, DNA Script, DNAtrix, DNX Biopharmaceuticals, DolCas Biotech, Domain Therapeutics, Dong-A Pharmaceutical, Dong-A ST, DongKoo Bio & Pharma, Dorian Therapeutics, Dow AgroSciences, Dow Chemical, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dr. U Devices, Draeger Safety Diagnostics, Dragonfly Therapeutics, Dr Allen Wu, DreaMed Diabetes, Drexel University, DRI Capital, Dr Kerklaan Therapeutics, DSM, DSM Sinochem Pharmaceuticals, Dual Therapeutics, DuChemBio, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke University, DuPont, Durata Therapeutics, Durect, Dynacure, Dynamic Combinatorial Chemistry, Dyna Therapeutics, Dynavax Technologies, Dyno Therapeutics, E-Scape Bio, Eagle Genomics, Eagle Pharmaceuticals, EA Pharma, Eastern Cooperative Oncology Group, Easton Pharmaceuticals, EB Pharma, ECM Therapeutics, Ecolab, Ecole Polytechnique Federale de Lausanne, EcoPesticides, EDAP TMS, Eddingpharm, Edelris, Edesa Biotech, Edinburgh Innovations, Edison Pharmaceuticals, Editas Medicine, Educational and Scientific, Edwards Lifesciences, eFFECTOR Therapeutics, EffRx, Egalet, Ehave, EhmetDx, Eiger BioPharmaceuticals, Eiken Chemical, EIP Eczacibasi Ilac Pazarlama, EirGenix, EirGen Pharma, Eisai, Eisai Inc, Ekso Bonics, Elanco, Elasmogen, Elcelyx Therapeutics, Elekta, Elektrofi, Elemaster Group, Elevar Therapeutics, Eleven Biotherapeutics, Elexopharm, Eli Lilly, Elis Pharmaceuticals, Elite Pharmaceuticals, Elixirgen, Ellipses Pharma, Elpis Biomed, ElsaLys Biotech, Eltima Software, Elysium Health, EmboMedics, Emcure Pharmaceuticals, EMD Millipore, EMD Serono, Emendo Biotherapeutics, Emerald Organic Growth, Emerge Health, Emergence Therapeutics, Emergent BioSolutions, Emergex Vaccines, Emisphere, Emmaus Life Sciences, Emollivet, Emory University, Empowered Diagnostics, EMS, Encore Dermatology, Endocanna Health, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Pharmaceuticals, Endo Ventures, Engage Therapeutics, enGene, EnGeneIC, Engitix, Enigma Biomedical, Enleofen Bio, Enlibrium, Enochian Biosciences, Ensemble Therapeutics, Entasis Therapeutics, Entera Health, Enteris Biopharma, Enterome Bioscience, Enterprise Partners Venture Capital, Enthera, Entos Pharmaceuticals, Entrinsic Health Solutions, Enumeral Biomedical, EnWave, ENYO Pharma, Enzymotec, Eolas Therapeutics, EOS Imaging, EpicentRx, Epic Pharmaceuticals, EpiDestiny, Epigen Biosciences, Epigenomics, EPI Health, EpimAb Biotherapeutics, Epirus Biopharmaceuticals, Epitomee Medical, Epivax, EpiVax Therapeutics, Epizyme, Epsilogen, EQRx, Equillium, Equinox Science, Ergomed, ERS Genomics, Ervaxx, ES Cell International, Especificos Stendhal, EspeRare Foundation, Esperion Therapeutics, Espero Biopharma, Establishment Labs, Esteve, Eton Pharmaceuticals, Eucodis Bioscience, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Therapeutics, Eurofarma, Eurofins Genomics, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Commission, European Equity Partners, EUSA Pharma, Eutilex, Eve & Co, Evecxia, Evelo Biosciences, Event Cardio Group, Everads Therapy, Everest Medicines, EverInsight Therapeutics, Evestra, Evolva, Evonik Industries, Evotec, Evox Therapeutics, Ewopharma, Exact Sciences, Exagen Diagnostics, Excelimmune, ExcellaBio, Excelra, Excision BioTherapeutics, Exelixis, Exeltis, Exicure, Exiqon, Exonics Therapeutics, ExoStat Medical, Exovita Biosciences, Expedeon, ExpreS2ion Biotechnologies, Expression Therapeutics, ExScientia, Exzell Pharma, Eyegate Pharmaceuticals, Eyenovia, Eyeon Therapeutics, EyePoint Pharmaceuticals, Eyevance, F-Star, F1 Oncology, F2G, FAAH Pharma, Facit, Factorial Diagnostics, Faes Farma, Fagron, Famy Care, Fate Therapeutics, Fatro, Fauna Bio, Fedora Pharmaceuticals, Feel Better, Feldan Therapeutics, Femtogenix, Ferozsons Laboratories, Ferrer International, Ferring Pharmaceuticals, FetoLumina Technologies, FGH Biotech, Fibriant, Fibrocell Science, Fibrocor Therapeutics, Fibrogen, Fidia Farmaceutici, Fina Biosolutions, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., Five Prime Therapeutics, FKD Therapies, Flamel Technologies, Flexion Therapeutics, FloDesign Sonics, Florida State University, Flower One, Flow Pharma, Fluicell, Fluidigm, Fluoresentric, Flynn Pharma, Foamix Pharmaceuticals, FOB Synthesis, Foghorn Therapeutics, Fondazione San Raffaele, Fondazione Telethon, Food and Drug Administration (FDA), Forage Genetics, Forendo Pharma, Foresee Pharmaceuticals, Forge Therapeutics, Formac Pharmaceuticals, FORMA Therapeutics, Formula Pharmaceuticals, Forte Biotechnology, Fortify Therapeutics, Fortress Biotech, Forty Seven, Forward Pharma, Fosun Pharmaceutical, Foundation for Celiac Disease Outcome Measures, Foundation Medicine, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Microelectronic Circuits and Systems, Fraunhofer Institute for Molecular Ecology (IME), Fred Hutchinson Cancer Research Center, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Frontier Biotech, Front Range Biosciences, Fscan, FSD Pharma, Fudan University, Fuhong Hanlin, Fujifilm, Fujifilm Kyowa Kirin Biologics, Fujifilm Pharma, Fuji Pharma, Fujirebio Diagnostics, Fulcrum Therapeutics, Fulgent Pharma, Fundacion Medina, Fundacion Progreso y Salud, Fusion Antibodies, Fusion Pharmaceuticals, FuturaGene, G-Tech Bio, G-treeBNT, G1 Therapeutics, G2B Pharma, G3 Pharmaceuticals, Gadeta, Gaia, Galapagos, Galaxy Biotech, Galderma, Galen, Galena Biopharma, Galmed Pharmaceuticals, GamaMabs Pharma, Gan & Lee, GB Sciences, GCA Therapeutics, GC LabCell, GC Pharma, Gebro Pharma, Gedeon Richter, GE Healthcare, Gelesis, Gemini Therapeutics, GEMoaB, Gemphire, Gen-Probe, GEn1E Lifesciences, Gen9, Genable Technologies, Genagon Therapeutics, GenAhead Bio, Genco Sciences, GeneBay, Gene Biotherapeutics, Genective, GeneData, GenEdit, Geneia, GeneNews, Genentech, Geneos Therapeutics, GeneQuine Biotherapeutics, General Biologicals, Generex Biotechnology, Genesee BioMedical, GeneSeek, Genestack, Genethon, Genetic Analysis, Genetic Immunity, Genetic Information Research Institute, Genetic Technologies, GeNeuro, Genevant Sciences, Genexine, Genexo, Genfit, Genialis, Genisphere, Genkyotex, Genmab, Genocea Biosciences, GenoDive Pharma, GenoLogics, Genomic Health, Genomic Vision, Genomma Lab Internacional, Genor Biopharma, genOway, Genprex, GenScript Biotech, GenSignia IP, GensKey Medical Technology, GenStem Therapeutics, GentiBio, Genticel, Genus, GenVec, Genzyme, Georgetown University, George Washington University, Georgia State University, Georgia State University Research Foundation (GSURF), Georgia Tech Research Corporation, German Cancer Research Center, Geron, Gestion Univalor, Gestvision, Gibson Oncology, GID Group, Gilead Sciences, Glaukos, GlaxoSmithKline, GlaxoSmithKline Biologicals, GL Brands, Glenmark Pharmaceuticals, Glide, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Diagnostics, Global Drug Development Centre (GDCC) China, Global Dx, Global Orthopaedic Technology, Global Response Aid, Globavir Biosciences, GlycoBac, Glycocept, GlycoMimetics, Glycostem Therapeutics, Glycotope Biotechnology, Glycyx Pharmaceuticals, Glythera, Gnosis Bioresearch, GNS Healthcare, Gold Coast Therapeutics, Goldfinch Bio, Goliver Therapeutics, Good Start Genetics, Goodwin Biotechnology, Google, Gossamer Bio, GO Therapeutics, Gour Medical, Grace Bio-Labs, Grail, Gravocore, GrayBug, Greatbatch, Great Belief International, Grenco Science, Grid Therapeutics, Grifols, Gritstone Oncology, Grunenthal, Grupo Ferrer, Grupo Juste, GS, GT Biopharma, GTx, Guangzhou Xiangxue Pharmaceutical, Gubra, Guided Therapeutics, Guilin Pharmaceutical, Gurnet Point Capital, Gynial, Gyros Protein Technologies, H&P Labs, H3 Biomedicine, Hackensack Meridian Health, Hadasit Bioholdings, Hadasit Medical Research Services and Development, Haibo Biotechnology Institute, Hai Kang Life, Hainan Sinotau Pharmaceutical, Hairmore Group, Haisco Pharmaceutical, HalioDx, Halo Dx, Halo Labs, Halozyme Therapeutics, Halt Medical, Halyard Health, Hamad Medical, Hamamatsu Photonics, Hammock Pharmaceuticals, HanAll Pharmaceuticals, Hancock Jaffe Laboratories, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hannover Medical School, Hansa Biopharma, HanX Biopharmaceuticals, Hao Le Ku (Beijing) Infant And Maternity, Haplogen, HAPPYneuron, Hapten Sciences, Harbin Gloria Pharmaceuticals, Harbour Antibodies, Harbour Biomed, Harmony Biosciences, Harpoon Medical, Harpoon Therapeutics, Harvard Medical School, Harvard University, Haselmeier, Hatch Medical, Hatchtech, Healeon Medical, Healios K.K., Health Canada, Healthcare Global Enterprises, HealthLytix, HealthMyne, HealthPointe Solutions, Health Sciences Research Institute Germans Trias i Pujol Foundation, Healthy Focus, Healthy Grain, HeartHero, Heart Imaging Technologies, Heat Biologics, HEC Pharm, Hefei Life Science, Hefei Tianhui Incubation of Technologies, Heidelberg Pharma, HekaBio, Helen F Graham Cancer Center, Helius Medical Technologies, Helix BioPharma, Helmholtz Zentrum Munchen, Helsinn Healthcare, Helsinn Therapeutics, HemispheRx Biopharma, HemoCleanse, Hemogenomics Pharma, Hemogenyx, HemoShear, Hemostemix, Henlius Biotech, Hennig, Henry Ford Health System, Heraeus, HerbalScience Group, Herbolea Biotech, Hesperos, Hetero Labs, Heumann Pharma Generics, HiberGene Diagnostics, HiFiBio, Highland Pharmaceutical, Hikma Pharmaceuticals, Hill Dermaceuticals, Histocell, Histogen, Histogenics, Histogen Oncology, Hisun BioRay, HitGen, HLS Therapeutics, Hoffmann La Roche, HoliStick Medical, Hologic, HoMedics, Homology Medicines, Honeywood, Hongene Biotechnology, Hong Kong Polytechnic University, Honor, Hookipa Pharma, HOPE BIOSCIENCES, Hope Medicine, Horama, Horizon Discovery, Horizon Pharma plc, Horus Pharma, Hospira, Hoth Therapeutics, Hough Ear Institute, Houston Pharmaceuticals, Hovione, Hsiri Therapeutics, HSRx Group, Huami, Huapont Pharma, Hubrecht Organoid Technology, Humabs BioMed, Humacyte, Humanigen, Human Life CORD Japan, Human Longevity, Humavox, Hummingbird Bioscience, Huntsman Cancer Institute, Huons, HUYA Bioscience, Hydra Biosciences, HydroCision, Hyundai Pharmaceutical, I-mab, IACTA Pharmaceuticals, IBA, IBC Generium, iBio, Icagen, Icahn School of Medicine at Mount Sinai, IcanoMAB, ICB Pharma, Ice + Jam, iCeutica, Ichor Medical Systems, ICL, ICM, Iconic Therapeutics, iDD Biotech, Ideal Medical Solutions, IDEAYA Biosciences, Idengene, Idera Pharmaceuticals, IDIBELL, Idorsia, ID Pharma, IDT, Igenica, Ignyta, Iksuda Therapeutics, Ildong Pharmaceutical

 

For a full list of companies please contact us on enquiry@currentpartnering.com

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.